Doctors weigh in on Ozempic, Wegovy, plus new ‘dual-action’ shot – Image for illustrative purposes only (Image credits: Pixabay)
Tampa, Fla. – Patients in the Tampa Bay area have increasingly sought out medications to manage weight and blood sugar levels. Local physicians note a sharp uptick in prescriptions for GLP-1 drugs such as Ozempic and Wegovy. These treatments replicate a hormone the body produces to control appetite and digestion, offering hope for those struggling with obesity and related conditions.[1][2]
How These Popular Shots Mimic the Body’s Signals
GLP-1 medications target a natural gut hormone that plays several key roles in metabolism. They help regulate blood sugar by prompting insulin release when needed. The drugs also slow the rate at which food exits the stomach, which prolongs feelings of fullness after meals.
Most patients receive these as weekly injections delivered just beneath the skin. Pill forms exist as well, though absorption can vary compared to the shots. This mechanism addresses both diabetes management and weight control, making the class versatile for clinical use.[1]
One Practice Where Demand Has Exploded
In a Tampa clinic, the shift toward these therapies has been dramatic. Dr. Luke Williams observed that a large portion of his patients now rely on them. “I would say in this practice, probably 70% of my patients are on this medication in some way or form,” he said.[2]…